Hormone Molecular Biology and Clinical Investigation, published by WALTER DE GRUYTER GMBH, is a pivotal journal within the realms of Endocrinology, Diabetes and Metabolism, and Molecular Biology, contributing significant insights to the field since its inception in 2010. With an ISSN of 1868-1883 and an E-ISSN of 1868-1891, this esteemed journal operates from its headquarters in Berlin, Germany. As a further testament to its growing influence, the journal has achieved respectable category quartile rankings in 2023, including Q3 in Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous), alongside Q4 in Molecular Biology. While currently not open access, the journal is dedicated to disseminating high-quality research aimed at understanding hormone-related mechanisms, clinical applications, and the biochemical pathways that underpin human health. The rich variety of articles published in Hormone Molecular Biology and Clinical Investigation make it an invaluable resource for researchers, medical professionals, and students seeking to deepen their knowledge in these critical scientific areas.

Neuropeptides is a prestigious, peer-reviewed journal published by Elsevier, focusing on the critical role of neuropeptides in various biological processes and their implications in cellular and molecular neuroscience, endocrinology, and neurology. With an impact factor reflecting its influence in the field and a diverse audience ranging from researchers to healthcare professionals, the journal serves as an essential platform for the dissemination of groundbreaking research from 1980 to 2024. Adhering to high academic standards, Neuropeptides holds a Q3 ranking in Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems, alongside a solid Q2 ranking in both Endocrinology and Neurology. This positions the journal at the forefront of its disciplines, contributing valuable insights into the understanding of neuropeptide functions in health and disease. By not operating as an Open Access journal, it ensures sustainability in the publishing process while upholding rigorous review standards. Researchers, professionals, and students are encouraged to engage with the findings published in this journal, which plays a vital role in advancing knowledge and fostering collaboration within the neuroscientific community.

DOMESTIC ANIMAL ENDOCRINOLOGY, published by Elsevier Science Inc., is a leading academic journal dedicated to advancing the field of endocrinology as it pertains to domestic animals. With an ISSN of 0739-7240 and an E-ISSN of 1879-0054, this journal serves a crucial role in disseminating high-quality research and insights that bridge veterinary science and animal physiology. The journal is recognized for its impactful contributions, boasting an impressive Q1 ranking in Animal Science and Zoology, further solidified by its prominent positioning in related fields such as Veterinary Science and Food Animals. Covering research from 1984 to 2025, DOMESTIC ANIMAL ENDOCRINOLOGY is an essential resource for researchers, professionals, and students seeking to deepen their understanding of hormonal functions and their implications in animal health and production. Despite not being an Open Access publication, it provides vital access options for institutions and individuals, ensuring that groundbreaking studies reach practitioners and scholars alike.

JOURNAL OF ENDOCRINOLOGY, established in 1946 and published by BIOSCIENTIFICA LTD, stands as a premier scholarly outlet in the field of endocrinology, diabetes, and metabolism. With an impressive H-Index reflecting its significant contribution to the literature, this journal maintains a strong presence in academic circles, evidenced by its Q1 ranking in the 2023 Scopus categories for both Endocrinology and Diabetes and Metabolism. With its targeted scope serving a global audience of researchers, professionals, and students, it provides a vital platform for disseminating innovative research findings and advancing the scientific understanding of endocrine systems. As we approach its convergence year of 2024, JOURNAL OF ENDOCRINOLOGY remains committed to publishing high-quality, peer-reviewed articles that explore cutting-edge developments in the field, thereby impacting clinical practices and guiding future research directions.

Reproductive Biology is a premier academic journal published by Elsevier, dedicated to advancing the field of reproductive science. With an ISSN of 1642-431X and an E-ISSN of 2300-732X, this journal has been serving the scientific community since its inception in 2001. It notably holds a Q1 ranking in Animal Science and Zoology as of 2023, underscoring its significant impact and prominence in this domain. The journal encompasses a wide array of topics surrounding reproductive biology, including but not limited to endocrinology and developmental processes, making it an essential resource for researchers and practitioners. Although it operates under a traditional access model, its comprehensive scope offers valuable insights that contribute to advancements in reproductive health, animal conservation, and biotechnology. Published in the Netherlands, Reproductive Biology aims to foster interdisciplinary collaboration and innovation, ultimately enriching our understanding of reproductive mechanisms across various species. Researchers, professionals, and students alike will find this journal an indispensable platform for disseminating groundbreaking research and engaging with the latest findings in reproductive science.

American Journal of Physiology-Endocrinology and Metabolism, published by the American Physiological Society, stands as a leading platform for disseminating high-quality research in the fields of endocrinology, diabetes, and metabolism, as well as general physiology. With an impressive impact factor placing it within the Q1 category across multiple relevant disciplines (Endocrinology, Diabetes and Metabolism; Physiology; and Medical Physiology), this journal reflects its authoritative position in the scientific community. Spanning from 1980 to 2024, the journal consistently publishes groundbreaking studies and significant findings that advance our understanding of hormonal regulation and metabolic processes. Although it does not currently offer open access, it provides valuable resources for researchers, professionals, and students alike, eager to stay at the forefront of advancements in physiological sciences. Addressed in Rockville, Maryland, its commitment to excellence and rigorous peer review ensures that every article contributes essential insights to the field.

Nature Reviews Endocrinology is a premier journal published by NATURE PORTFOLIO, providing comprehensive and critical reviews in the rapidly evolving field of endocrinology. Established to foster advanced understanding, it has become a vital resource for researchers, professionals, and students alike. With an impressive impact factor and a prominent ranking of Q1 in both Endocrinology and Endocrinology, Diabetes, and Metabolism categories for 2023, the journal is recognized for its high-quality research dissemination, evidenced by its rankings of #2 out of 244 in Medicine and #2 out of 128 in Biochemistry, Genetics, and Molecular Biology. Spanning the years from 2009 to 2024, it focuses on publishing cutting-edge information that shapes current scientific knowledge and clinical practices. The journal offers open access options, ensuring greater visibility and reach for its articles. Located in Germany, this journal remains at the forefront of endocrinology research, significantly contributing to the understanding of hormonal functions and their implications on health. Discover the latest advancements and insights by exploring Nature Reviews Endocrinology.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY is a distinguished peer-reviewed journal published by Pergamon-Elsevier Science Ltd, committed to advancing the fields of biochemistry, molecular biology, and endocrinology. With an ISSN of 0960-0760 and an E-ISSN of 1879-1220, this journal has garnered a notable reputation, securing a Q2 ranking in numerous categories, including Biochemistry, Cell Biology, and Clinical Biochemistry, as of 2023. Hailing from the United Kingdom, it serves as a critical platform for the dissemination of impactful research from 1990 to 2025 and beyond. Although it does not currently offer open access options, the journal's comprehensive coverage and rigorous peer review process ensure high-quality publications that significantly contribute to the understanding of steroid biochemistry and related fields. Targeting a diverse audience of researchers, professionals, and students, the journal remains an essential resource for those seeking to stay at the forefront of scientific innovation and discovery.

Comparative Biochemistry and Physiology B: Biochemistry & Molecular Biology, published by Elsevier Science Inc, is a premier journal dedicated to the field of biochemistry and molecular biology with a specific focus on comparative analyses across various biological systems. Since its inception in 1971, the journal has made significant contributions to our understanding of the biochemical and physiological processes that differentiate organismal function across animal and aquatic life. The journal holds a commendable position in the academic community, evidenced by its 2023 rankings, which place it in the second quartile for Animal Science and Zoology and Aquatic Science, and the third quartile for both Biochemistry and Molecular Biology as well as Physiology. Researchers and students can access cutting-edge research through this highly respected publication, which continues to influence the future of biological sciences. While currently not an Open Access journal, its rigorous peer-review process ensures that only high-quality articles are disseminated, further solidifying its role as a critical resource for professionals and academics alike seeking to explore the intricate relationships between biochemical structures and physiological functions.

JOURNAL OF MOLECULAR ENDOCRINOLOGY, published by BIOSCIENTIFICA LTD, is a prestigious academic journal that has made significant contributions to the fields of endocrinology and molecular biology since its inception in 1988. With an impressive impact factor that places it in the Q1 category for Endocrinology and Q2 for Molecular Biology, this journal is recognized for its rigorous peer-reviewed research that addresses key questions at the intersection of molecular mechanisms and hormonal regulation. The journal's accessibility within the Scopus rankings, notably positioned 45th out of 128 in Endocrinology, highlights its relevance and influence in shaping contemporary scientific discourse. Although the journal does not currently offer open access options, it remains an essential resource for researchers, professionals, and students eager to explore groundbreaking discoveries and advancements in the hormonal sciences. The JOURNAL OF MOLECULAR ENDOCRINOLOGY continues to pave the way for critical exploration and innovation, ensuring its place as a vital publication for the advancement of knowledge in molecular endocrinology.